We are live on ! Find out more
QOP

Quinn Opportunity Partners Portfolio holdings

AUM $1.92B
1-Year Est. Return 31.26%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+31.26%
3 Year Est. Return
+67.23%
5 Year Est. Return
+49.99%
10 Year Est. Return
+245.23%
AUM
$2.37B
AUM Growth
+$959M
Cap. Flow
+$955M
Cap. Flow %
40.29%
Top 10 Hldgs %
35.28%
Holding
421
New
90
Increased
94
Reduced
62
Closed
52

Sector Composition

Rank Sector Weight
1 Communication Services 31.86%
2 Consumer Discretionary 15.78%
3 Healthcare 11.2%
4 Technology 10.25%
5 Consumer Staples 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQ icon
351
iQIYI
IQ
$1.31B
$108K ﹤0.01%
56,001
LOCO icon
352
El Pollo Loco
LOCO
$463M
$105K ﹤0.01%
10,000
RPTX
353
DELISTED
Repare Therapeutics
RPTX
$104K ﹤0.01%
40,000
CLAR icon
354
Clarus
CLAR
$145M
$103K ﹤0.01%
+30,635
New +$104K
GPRE icon
355
Green Plains
GPRE
$1.06B
$99K ﹤0.01%
10,100
SSYS icon
356
Stratasys
SSYS
$769M
$96.7K ﹤0.01%
11,144
PAGS icon
357
PagSeguro Digital
PAGS
$2.54B
$96.4K ﹤0.01%
10,000
FUBO icon
358
FuboTV Inc
FUBO
$276M
$75.6K ﹤0.01%
2,500
BOOM icon
359
DMC Global
BOOM
$153M
$73.6K ﹤0.01%
11,000
HAIN icon
360
Hain Celestial
HAIN
$53.4M
$64.2K ﹤0.01%
60,000
BHR
361
Braemar Hotels & Resorts
BHR
$139M
$57.4K ﹤0.01%
20,000
SLQT icon
362
SelectQuote
SLQT
$123M
$56.4K ﹤0.01%
40,000
RXT icon
363
Rackspace Technology
RXT
$1.2B
$56.1K ﹤0.01%
57,750
NRDY icon
364
Nerdy
NRDY
$93.5M
$40.7K ﹤0.01%
39,155
-10,000
-20% -$11.3K
NNBR icon
365
NN Inc
NNBR
$300M
$32K ﹤0.01%
+25,000
New +$38.2K
ACIU icon
366
AC Immune
ACIU
$232M
$31.7K ﹤0.01%
10,100
NDLS icon
367
Noodles & Co
NDLS
$96M
$24.7K ﹤0.01%
4,375
FATE icon
368
Fate Therapeutics
FATE
$322M
$19.7K ﹤0.01%
20,000
MVIS icon
369
Microvision
MVIS
$86.9M
$16.6K ﹤0.01%
1,333
ABVX
370
Abivax
ABVX
$11.1B
-31,000
Closed -$2.63M
ACB
371
Aurora Cannabis
ACB
$179M
-20,100
Closed -$120K
ADVM
372
DELISTED
Adverum Biotechnologies
ADVM
-41,418
Closed -$188K
ANGI icon
373
Angi Inc
ANGI
$186M
-12,234
Closed -$199K
AQST icon
374
Aquestive Therapeutics
AQST
$538M
-10,100
Closed -$56.5K
BA icon
375
Boeing
BA
$184B
-5,000
Closed -$1.08M

Similar funds

Quinn Opportunity Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Quinn Opportunity Partners held 421 positions worth $2.37B, up 68% from $1.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Quinn Opportunity Partners deployed $955M of net new capital in Q4 2025, opening 90 new positions and adding to 94 existing holdings. Its largest new stake was Hologic: 693,600 shares worth $51.7M.

By sector, the portfolio is most concentrated in Communication Services at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Cytokinetics, an estimated $14.7M trimmed.

  • Quinn Opportunity Partners's largest Q4 2025 buy was Hologic: 693,600 shares worth $51.7M.
  • Quinn Opportunity Partners added most to Electronic Arts in Q4 2025, an estimated $152M increase.
  • Quinn Opportunity Partners's biggest Q4 2025 reduction was Cytokinetics, cutting an estimated $14.7M.
  • Quinn Opportunity Partners fully exited Paramount Group in Q4 2025, selling an estimated $16M.
  • Quinn Opportunity Partners's ten largest holdings make up 35% of its $2.37B portfolio in Q4 2025.
  • Quinn Opportunity Partners opened 90 new positions and closed 52 in Q4 2025.
  • Quinn Opportunity Partners's portfolio value rose 68% quarter-over-quarter to $2.37B.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.